×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Century Therapeutics Inc. (IPSC) NASDAQ

$4.27 0.29 (7.29%)

Market Cap: $276.77M

As of 03/27/24 04:00 PM EDT. Market closed.

(IPSC)

Century Therapeutics Inc. (IPSC)
NASDAQ

$4.27
0.29 (7.29%)

Market Cap: $276.77M

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research ... read more

Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Lalo Flores
Full Time Employees
102
URL
Address
3675 Market Street, PA, Philadelphia, 19104.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Lalo Flores
Full Time Employees
102
Address
3675 Market Street, PA, Philadelphia, 19104.
PRICE CHART FOR CENTURY THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$3.98
Days Range
$3.86 - $4.39
52 week range
$1.28 - $5.51
Volume
0
Avg. Volume (30 days)
139,372
Market Cap
$276.77M
Dividend Yield
-
P/E
(2.03)
Shares Outstanding
64,817,863
Open
-
Previous Close
$3.98
Days Range
$3.86 - $4.39
52 week range
$1.28 - $5.51
Volume
0
Avg. Volume (30 days)
139,372
Market Cap
$276.77M
Dividend Yield
-
P/E
(2.03)
Shares Outstanding
64,817,863
FINANCIAL STATEMENTS FOR CENTURY THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR CENTURY THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Farid AdrienneChief Operations OfficerMar 07, 2024 Option Exercise$1.0322,83123,516136,980Mar 08, 2024, 06:29 PM
Farid AdrienneChief Operations OfficerMar 06, 2024 Option Exercise$1.0330,68431,605144,833Mar 08, 2024, 06:29 PM
Farid AdrienneChief Operations OfficerMar 07, 2024 Sale$5.1422,831117,342114,149Mar 08, 2024, 06:29 PM
Farid AdrienneChief Operations OfficerMar 06, 2024 Sale$4.9630,684152,340114,149Mar 08, 2024, 06:29 PM
Farid AdrienneChief Operations OfficerFeb 16, 2024 Option Exercise$1.03485500114,634Feb 21, 2024, 04:10 PM
Farid AdrienneChief Operations OfficerFeb 16, 2024 Sale$4.864852,358114,149Feb 21, 2024, 04:10 PM
Carr DouglasSVP Finance & OperationsFeb 06, 2024 Sale$4.495572,499303,580Feb 07, 2024, 05:21 PM
Carr DouglasSVP Finance & OperationsFeb 05, 2024 Sale$3.846432,470304,137Feb 07, 2024, 05:21 PM
Farid AdrienneChief Operations OfficerFeb 06, 2024 Sale$4.491,7848,005114,149Feb 07, 2024, 05:21 PM
Farid AdrienneChief Operations OfficerFeb 05, 2024 Sale$3.842,0357,816115,933Feb 07, 2024, 05:21 PM
Carr DouglasSVP Finance & OperationsNov 01, 2023 Option Exercise$1.4916,61124,750304,780Nov 03, 2023, 04:04 PM
Diem Michael CraigChief Financial OfficerNov 01, 2023 Option Exercise$1.4920,76330,937253,533Nov 03, 2023, 04:04 PM
Borges LuisChief Scientific OfficerApr 03, 2023 Option Exercise$1.037,4527,676256,535Apr 05, 2023, 04:27 PM
Borges LuisChief Scientific OfficerMar 23, 2023 Option Exercise$1.03220,930227,558264,680Mar 23, 2023, 07:31 PM
Borges LuisChief Scientific OfficerMar 22, 2023 Option Exercise$1.0365,69867,669109,448Mar 23, 2023, 07:31 PM
Borges LuisChief Scientific OfficerMar 21, 2023 Option Exercise$1.0363,61665,524107,366Mar 23, 2023, 07:31 PM
Borges LuisChief Scientific OfficerMar 23, 2023 Sale$3.5515,59755,369249,083Mar 23, 2023, 07:31 PM
Borges LuisChief Scientific OfficerMar 22, 2023 Sale$3.7265,698244,64043,750Mar 23, 2023, 07:31 PM
Borges LuisChief Scientific OfficerMar 21, 2023 Sale$3.7763,616239,87043,750Mar 23, 2023, 07:31 PM
Versant Venture Capital VI, L.P.10% OwnerAug 09, 2022 Sale$13.03550,0007,166,61011,816,814Aug 11, 2022, 04:55 PM
BAYER AKTIENGESELLSCHAFT10% OwnerJun 22, 2021 Buy$20.00750,00015,000,00012,675,838Jun 23, 2021, 04:41 PM
Versant Venture Capital VI, L.P.10% OwnerJun 22, 2021 Buy$20.00100,0002,000,000714,095Jun 23, 2021, 04:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Farid AdrienneChief Operations Officer03/07/202423,516
Farid AdrienneChief Operations Officer03/06/202431,605
Farid AdrienneChief Operations Officer03/07/2024117,342
Farid AdrienneChief Operations Officer03/06/2024152,340
Farid AdrienneChief Operations Officer02/16/2024500
Farid AdrienneChief Operations Officer02/16/20242,358
Carr DouglasSVP Finance & Operations02/06/20242,499
Carr DouglasSVP Finance & Operations02/05/20242,470
Farid AdrienneChief Operations Officer02/06/20248,005
Farid AdrienneChief Operations Officer02/05/20247,816
Carr DouglasSVP Finance & Operations11/01/202324,750
Diem Michael CraigChief Financial Officer11/01/202330,937
Borges LuisChief Scientific Officer04/03/20237,676
Borges LuisChief Scientific Officer03/23/2023227,558
Borges LuisChief Scientific Officer03/22/202367,669
Borges LuisChief Scientific Officer03/21/202365,524
Borges LuisChief Scientific Officer03/23/202355,369
Borges LuisChief Scientific Officer03/22/2023244,640
Borges LuisChief Scientific Officer03/21/2023239,870
Versant Venture Capital VI, L.P.10% Owner08/09/20227,166,610
BAYER AKTIENGESELLSCHAFT10% Owner06/22/202115,000,000
Versant Venture Capital VI, L.P.10% Owner06/22/20212,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN CENTURY THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,518,9960.00013%-4.77%Other
BAKER BROS. ADVISORS LP797,4600.03%-30.62%Other
GEODE CAPITAL MANAGEMENT, LLC468,4570.00016%0.81%Other
RENAISSANCE TECHNOLOGIES LLC119,2000.00061%35.92%Other
CHANGE IN SHARES OUTSTANDING FOR CENTURY THERAPEUTICS INC
STOCK BUYBACKS FOR CENTURY THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.92%
1Q
12/31/2023
06/30/2023
1.26%
2Q
12/31/2023
03/31/2023
2.36%
3Q
12/31/2023
12/31/2022
2.90%
4Q
12/31/2023
09/30/2022
3.49%
5Q
12/31/2023
06/30/2022
4.01%
6Q
12/31/2023
03/31/2022
5.16%
7Q
12/31/2023
12/31/2021
85.21%
8Q
12/31/2023
09/30/2021
10.14%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.92%
1Q
06/30/2023
1.26%
2Q
03/31/2023
2.36%
3Q
12/31/2022
2.90%
4Q
09/30/2022
3.49%
5Q
06/30/2022
4.01%
6Q
03/31/2022
5.16%
7Q
12/31/2021
85.21%
8Q
09/30/2021
10.14%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CENTURY THERAPEUTICS INC
LOADING...